|
Delayed
Toronto S.E.
06:59:34 20/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 9.180 CAD | -0.76% |
|
-14.29% | +15.91% |
| 06/10 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 05/10 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.76% | -14.29% | -29.55% | -25.31% | +15.91% | -4.38% | +91.25% | -47.60% | - | 138M | |
| +1.52% | -7.19% | -8.44% | +24.27% | +61.63% | +51.66% | +69.99% | +1.03% | - | 65.83B | |
| +1.70% | +10.03% | +13.56% | +10.30% | +15.88% | +12.69% | +87.20% | -15.19% | +236.68% | 51.87B | |
| +5.97% | +7.63% | -10.90% | +2.63% | +7.90% | +5.95% | +70.62% | +203.89% | +5,200.89% | 51.2B | |
| +0.85% | +2.65% | -0.85% | +31.24% | +18.71% | +26.19% | +45.15% | +6.39% | +259.57% | 43.76B | |
| +1.41% | +7.60% | +2.71% | +20.94% | +23.63% | +17.89% | +127.34% | +0.80% | +1,038.86% | 42.09B | |
| +5.99% | +2.69% | +0.38% | +7.27% | +142.94% | +258.27% | +591.81% | +618.53% | - | 39.04B | |
| +2.16% | +9.87% | +10.48% | +12.74% | +14.98% | +18.92% | +59.70% | +10.58% | +163.35% | 34B | |
| +3.84% | -2.34% | -5.57% | +30.82% | +59.19% | +39.18% | +8.57% | -57.11% | - | 25.2B | |
| +1.73% | +5.02% | +14.78% | +40.44% | +27.97% | +30.58% | +25.68% | -11.41% | +124.39% | 22.8B | |
| -0.47% | +0.10% | -9.08% | -3.32% | -6.41% | -17.46% | -1.99% | -66.93% | - | 22.41B | |
| +1.01% | -0.14% | -20.12% | -9.69% | -44.47% | -42.44% | +285.37% | +261.85% | +586.92% | 20.81B | |
| +1.82% | +3.09% | +0.73% | +19.10% | +11.95% | +15.49% | +174.27% | +234.36% | +1,934.15% | 17.3B | |
| -5.62% | -0.84% | -0.42% | -1.67% | +177.32% | +152.60% | +367.34% | +1,438.75% | +717.19% | 14.99B | |
| +1.64% | +6.89% | +11.17% | +14.55% | +45.13% | +84.16% | +201.33% | +193.95% | +441.82% | 15.53B | |
| -1.17% | -0.51% | 0.00% | +9.79% | +25.10% | +22.16% | +69.73% | -30.29% | +84.58% | 15.37B | |
| +1.42% | +4.30% | -2.02% | -7.53% | - | - | - | - | - | 15.1B | |
| +3.02% | +3.09% | +10.48% | +40.30% | +54.53% | +67.40% | +66.25% | -26.86% | +271.39% | 14.32B | |
| +3.54% | +4.00% | -5.57% | -7.14% | +19.33% | -2.34% | +545.07% | - | - | 13.77B | |
| +4.09% | +6.22% | +2.95% | +5.04% | -4.20% | -7.37% | -23.01% | -36.83% | +106.02% | 12.97B | |
| Average | +1.72% | -0.51% | -1.26% | +10.74% | +35.11% | +38.38% | +150.61% | +148.77% | +858.91% | 26.93B | |
| Weighted average by Cap. | +2.19% | +0.04% | -0.24% | +14.42% | +36.67% | +42.87% | +139.08% | +125.75% | +1,153.67% |
- Stock Market
- Stocks
- MSCL Stock
- Sector Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
